Effects of in-line filtration on lipid particle size distribution in total nutrient admixtures

被引:23
作者
Driscoll, DF
Bacon, MN
Bistrian, BR
机构
[1] NEW ENGLAND DEACONESS HOSP,NUTR SUPPORT SERV,BOSTON,MA 02215
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA
关键词
D O I
10.1177/0148607196020004296
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: The recent Food and Drug Administration Safety Alert recommends in-line filtration for all total parenteral nutrition admixtures. Although rigid crystalline particulates can be effectively removed by in-line filters, the fate of flexible lipid droplets (LDs) enlarged through electromechanical destabilization is less clear. Lipid globules > 5 mu m could lodge in the pulmonary microvasculature and produce an embolic syndrome. Recent evidence suggests that TNAs (Total Nutrient Admixtures) with LDs of 5 mu m or more constituting > 0.4% of the final fat concentration are unstable. Methods: Six pairs of 1.5-L TNA dispersions of varying degrees of stability were prepared in duplicate (n = 12) and studied over 30 hours. The number of enlarged fat globules was assessed by laser light extinction for all LDs greater than or equal to 1.75 mu m at 0, 6, 24, and 30 hours after preparation. After LD assessments at time 0, admixtures were placed in a temperature-controlled chamber at 25 degrees C +/- 0.1 degrees C. At 6 hours, a simulated patient infusion was begun using a 1.2-mu m filter at a continuous flow rate of 55 mL/h. Pre- and postfiltration samples were taken at 6, 24, and 30 hours, equal to times 0, 18, and 24 hours of the simulated infusion. A repeated measure two-way analysis of variance assessing treatment and time was performed. Dependent variable analyses included number-weighting of fat globules as > 5 mu m (LD1), total number greater than or equal to 1.75 mu m (LD2), LD1-LD2 ratio (as %), and volume-weighted percent of fat (PFAT) > 5 mu m. Results: In all cases, time was a significant factor and was an expected finding as the stability of all extemporaneously prepared admixtures deteriorates with time. Of the number-weighted variables, a significant postfiltrate reduction was observed in LD1 (p = .041), LD2 (p < .001), and LD1-LD2 ratio (p < .0001). Of greatest clinical importance, the volume-weighted PFAT > 5 mu m was significantly reduced by the in-line filter (p = .029). Conclusions: The TNA1 1.2-mu m filter significantly reduced the total number and concentration of enlarged fat globules. The higher LD1-LD2 ratio may reflect the effects of filtration on electrically destabilized fat globules. However, total exposure to unstable and very large LDs was significantly reduced, suggesting that in-line TNA filtration should be a standard part of nutrition therapy.
引用
收藏
页码:296 / 301
页数:6
相关论文
共 9 条
[1]  
Driscoll D F, 1995, Nutr Clin Pract, V10, P114, DOI 10.1177/0115426595010003114
[2]   PHYSICOCHEMICAL STABILITY OF TOTAL NUTRIENT ADMIXTURES [J].
DRISCOLL, DF ;
BHARGAVA, HN ;
LI, L ;
ZAIM, RH ;
BABAYAN, VK ;
BISTRIAN, BR .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (06) :623-634
[3]   TOTAL PARENTERAL-NUTRITION 1990 - A REVIEW OF ITS CURRENT STATUS IN HOSPITALIZED-PATIENTS, AND THE NEED FOR PATIENT-SPECIFIC FEEDING [J].
DRISCOLL, DF ;
BLACKBURN, GL .
DRUGS, 1990, 40 (03) :346-363
[4]  
DRISCOLL DF, 1987, NUTR CLIN PRACT, V2, P160
[5]  
Hill Steven E., 1996, Journal of Parenteral and Enteral Nutrition, V20, P81, DOI 10.1177/014860719602000181
[6]   A FACTORIAL DESIGN STUDY ON THE PHYSICAL STABILITY OF 3-IN-1 ADMIXTURES [J].
LI, LC ;
SAMPOGNA, TP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (11) :985-987
[7]   THE ELECTROKINETIC PROPERTIES OF PHOSPHOLIPID STABILIZED FAT EMULSIONS .5. THE EFFECT OF AMINO-ACIDS ON EMULSION STABILITY [J].
WASHINGTON, C ;
CONNOLLY, MA ;
MANNING, R ;
SKERRATT, MCL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 77 (01) :57-63
[8]   THE ELECTROKINETIC PROPERTIES OF PHOSPHOLIPID STABILIZED FAT EMULSIONS .4. THE EFFECT OF GLUCOSE AND OF PH [J].
WASHINGTON, C ;
ATHERSUCH, A ;
KYNOCH, DJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 64 (2-3) :217-222
[9]  
1994, AM J HOSP PHARM, V51, P427